About

Publications While At HealthPartners

selected publications

Journal Article

Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States. 

Journal of managed care & specialty pharmacy. 2024

Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm. 

Journal of Medical Economics. 2023

BBCIC Research Network analysis of first-cycle prophylactic G-CSF use in patients treated with high-neutropenia risk chemotherapy. 

Journal of the National Comprehensive Cancer Network. 2021

Patient characteristics and utilization patterns of short-acting recombinant granulocyte colony-stimulating factor (G-CSF) biosimilars compared to their reference product. 

Drugs - real world outcomes. 2021

Descriptive analysis of long- and intermediate-acting insulin and key safety outcomes in adults with type 2 diabetes mellitus. 

Journal of managed care & specialty pharmacy. 2019

Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to evaluate patterns of care. 

Journal of managed care & specialty pharmacy. 2019

Contact

full name

C. M. Lockhart

Quick Info

 

Collaboration

Co-author network

Map of science